Patterns of care in adjuvant systemic therapy of patients with stage III melanoma: A U.S. population-based study.
Comprehensive genomic and immune profiling of non-V600 BRAF-mutated melanomas: Implications for therapeutic strategies beyond BRAF/MEK inhibitors. This is an ASCO Meeting Abstract from the 2024 ASCO ...
In simple terms: a mutation is a stable change in genetic sequence that can be copied when cells or viruses replicate. Most mutations have no detectable effect, some contribute to disease, and a small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results